Delivery Order SPE2DB20D1109-SPE2DB24FP37B

Award Date 6/20/24
Potential Completion Date 6/21/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of LEVORPHANOL 2 MG TABLET 100S to the Defense Logistics Agency (DLA). The award, valued at $1,918.22, was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price and has an ultimate completion date of August 13, 2024. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide LEVORPHANOL 2 MG TABLET 100S, a pharmaceutical product, with a potential value of $1,918.22 and a completion date of March 5, 2024. This award is part of a larger indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and DLA Troop Support Medical, valued up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,860.82, is a delivery order for 4,568,150,902 tablets of the medication Levorphanol 2 mg. The contract has a completion date of May 7, 2025 and uses a firm fixed price pricing type. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp is a for-profit organization that...
This federal contract award, valued at $1,984.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Levorphanol 2 mg tablets, a prescription medication, to support federal healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,754.63 firm fixed-price delivery order is for the supply of 4561635024 Levorphanol 2 mg Tablets, with a completion date of July 31, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a Delivery Order (DO) valued at $2,625.38. The contract is for the supply of LEVORPHANOL TABS 2MG and has an ultimate completion date of February 20, 2025. The contracting agency is the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency under the Department of Defense. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of 4,560,068,580 units of Levorphanol Tablets 2mg to the Defense Logistics Agency (DLA) Troop Support Medical. The $9,330.59 Firm Fixed Price Delivery Order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 27, 2023, with a completion date of February 28, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is for the delivery of 100 units of the pharmaceutical product Levorphanol 2 mg tablets. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on September 18, 2024. The contract has a ceiling value of $2,115.35 and a completion date of September 19, 2024. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award, valued at $5,754.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company and subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,336,717 units of the 2 mg Levorphanol tablet, a prescription pain medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and an Ultimate Completion Date of January 17, 2024. It was awarded on January 16, 2024, and does not have...
This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) is a Delivery Order valued at $7,672.84 for the supply of Levorphanol 2 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that provides a comprehensive range of pharmaceutical products and medical supplies to support military...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FP37B
    Delivery Order

This federal contract award, valued at $1,918.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4564958463 - LEVORPHANOL 2 MG TABLET 100S. The contract is a Firm Fixed Price Delivery Order with a completion date of June 21, 2024. The award was made on June 20, 2024, and there was no set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/27/25, 10:46 AM